Skip to main content
. 2024 May 6;17(5):e021623. doi: 10.1136/jnis-2024-021623

Table 1. Comparison for the type of flow diverter device used before propensity score matching.

Variables Type of flow diverter device P value
PED TED Overall
735 (71.7%) 290 (28.3%) 1025
Demographic characteristics
Age (years) 54.00 (46.00, 61.00) 56.00 (47.00, 64.00) 55.00 (46.00, 62.00) 0.077
Gender, female 487 (66.3) 216 (74.5) 703 (68.6) 0.013*
Hypertension 282 (38.4) 121 (41.7) 403 (39.3) 0.358
Diabetes 77 (10.5) 39 (13.4) 116 (11.3) 0.214
Hyperlipidemia 244 (33.2) 93 (32.1) 337 (32.9) 0.785
Coronary disease 45 (6.1) 12 (4.1) 57 (5.6) 0.272
Ischemic stroke history 91 (12.4) 54 (18.6) 145 (14.1) 0.013*
Smoking status 100 (13.6) 23 (7.9) 123 (12.0) 0.016*
Alcohol abuse 82 (11.2) 16 (5.5) 98 (9.6) 0.008*
Preoperative mRS score >2 13 (1.8) 6 (2.1) 19 (1.9) 0.949
Morphological feature
Location <0.001*
 Internal carotid artery 584 (79.5) 256 (88.3) 840 (82.0)
 Distal circulation 32 (4.4) 25 (8.6) 57 (5.6)
 Vertebrobasilar artery 119 (16.2) 9 (3.1) 128 (12.5)
Aneurysm morphology <0.001*
 Saccular 606 (82.4) 273 (94.1) 879 (85.8)
 Non-saccular 129 (17.6) 17 (5.9) 146 (14.2)
Aneurysm size (mm) 7.59 (4.27, 14.20) 4.40 (3.10, 7.33) 6.29 (3.80, 12.40) <0.001*
Neck width (mm) 5.45 (3.60, 8.02) 4.18 (2.95, 5.54) 4.92 (3.32, 7.42) <0.001*
Parent vessel diameter (mm)† 3.71 (3.26, 4.20) 4.00 (3.41, 4.40) 3.78 (3.30, 4.25) <0.001*
Lumen disparities (mm)‡ 0.60 (0.30, 0.93) 0.98 (0.48, 1.36) 0.67 (0.34, 1.03) < 0.001*
Procedural details
Adjunctive coiling 242 (32.9) 41 (14.1) 283 (27.6) <0.001*
Overlapping stent technique 47 (6.4) 6 (2.1) 53 (5.2) 0.008*
Immediate occlusion state 88 (12.0) 19 (6.6) 107 (10.4) 0.015*
Device-related challenges 29 (3.9) 14 (4.8) 43 (4.2) 0.604
 Stent re-apposition 17 (2.3) 4 (1.37) 21 (2.1) 0.465
 Poor wall apposition 5 (0.7) 5 (1.72) 10 (1.0) 0.157
 Stent shortening 5 (0.7) 3 (1.0) 8 (0.8) 0.694
 Stent migration 1 (0.1) 2 (0.7) 3 (0.3) 0.195
 Intraoperative perforation 1 (0.1) 0 1 (0.1) >0.999
Perioperative complications 25 (3.4) 8 (2.8) 33 (3.2) 0.742
 Intraoperative rupture 1 (0.1) 1 (0.3) 2 (0.2) 0.486
 In-stent thrombosis 6 (0.8) 2 (0.7) 8 (0.8) >0.999
 Postoperative SAH 1 (0.1) 0 1 (0.1) >0.999
 Postoperative ICH 5 (0.7) 1 (0.3) 6 (0.6) >0.999
 Transient ischemic attack 7 (1.0) 0 7 (0.7) 0.201
 Mild ischemia 3 (0.4) 4 (1.4) 7 (0.7) 0.104
 Severe ischemia 2 (0.3) 0 2 (0.2) >0.999
Angiographic outcomes
Follow-up duration (months) 7.00 (6.00, 11.00) 9.00 (6.00, 15.00) 7.00 (6.00, 12.00) <0.001*
Occlusion status
 Complete occlusion 592 (80.5) 219 (75.5) 811 (79.1) 0.089
 Near-complete occlusion 44 (6.0) 32 (11.0) 76 (7.4) 0.008
 Incomplete occlusion 99 (13.5) 39 (13.4) 138 (13.5) >0.999
 Aneurysm occlusion (complete/near-complete) 636 (86.5) 251 (86.6) 887 (86.5) >0.999
ISS 126 (17.1) 48 (16.6) 174 (17.0) 0.893
Symptomatic ISS 14 (1.9) 5 (1.7) 19 (1.9) >0.999
Clinical outcomes
Follow-up duration (months) 18.00 (16.00, 19.00) 18.00 (17.00, 19.00) 18.00 (16.00, 19.00) 0.576
Favorable (mRS score 0–2) 727 (98.9) 285 (98.3) 1012 (98.7) 0.610
Morbidity (mRS score 3–5) 8 (1.1) 5 (1.7) 13 (1.3) 0.610
Mortality (mRS score 6) 0 0 0
Surgery-related morbidity 3 (0.4) 2 (0.7) 5 (0.5) 0.625

Values are shown as median (IQR) or frequency (%) unless indicated otherwise.

*

Values are shown as median () or frequency (%) unless indicated otherwise; *”, Sstatistical significance.

The mean diameter of the vessel at the proximal and distal ends of the aneurysms.

The absolute value of the difference between the proximal and distal parent diameter.

ICH, intraparenchymal hemorrhage; ISS, in-stent stenosis; mRS, modified Rankin Scale; PED, Pipeline embolization device; SAH, subarachnoid hemorrhage; TED, Tubridge embolization device.